Trial Profile
Evaluating long-term Effects of eslicarbazepine acetate on liver function tests, lipid metabolism tests and sodium values profile
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions
- 13 May 2016 New trial record